404
Equine Pharmaceuticals And Supplements Market Report
The report is delivered digitally through our online portal. Buyers receive login credentials from our team to access the report and may update their credentials at any time after the initial login.
Delivery timelines depend on the status of the report:
For the most accurate delivery timeline, please contact us to confirm the current status of the report.
Yes. You may request a complimentary preview of the report through a video conference with our team.
Yes. The scope of the report can be fully customized to align with your specific research objectives and information requirements.
Please contact us at [email protected], and our team will be happy to discuss your requirements and propose a tailored solution.
Yes. Selected sections of the report can be purchased separately based on your requirements. Please contact us at [email protected] to discuss your needs.
Yes, AI can help gather publicly available information, but its outputs are only as reliable as the data it accesses. Stratview Research reports are built using validated data, extensive primary interviews with industry stakeholders, and the expertise of our experienced research team.
Additionally, many critical insights, including market dynamics, competitive intelligence, and industry-specific trends, are not publicly available and therefore cannot be captured through AI alone.
The market is projected to grow from USD 898.04 million in 2021 to USD 1,194.31 million by 2028.
Zoetis (The US), Boehringer Ingelheim (Germany), Merck & Co (The US), Elanco Bayer (The US), Ceva Sante Animale (France), Virbac (France), Vetoquinol (France), Affymetrix (The US), and Celltrion (South Korea) are among the key players in the market.
The market is expected to grow at an impressive CAGR of 4.12% in the coming years.
Growing awareness regarding equine pharmaceuticals and supplements products and rising demand for herbal feed, digestive, and energy supplements owing to the choice among horse breeders for organic products are some of the factors driving the growth of the market.
Asia Pacific market garnered a significant market share in 2021 and is projected to grow at a healthy CAGR during the assessment period.
The pharmaceuticals segment is expected to register the fastest CAGR in the market.
Equine pharmaceuticals and supplements companies, Equine pharmaceuticals and supplements vendors, Horse owners and sellers, Horse riding event organizations, Horse race competition organizations are the target audience in the market.